Latest AI and machine learning research in metabolic syndrome for healthcare professionals.
BACKGROUND: The rising co-occurrence of cardiometabolic diseases and musculoskeletal degeneration poses a critical challenge to healthy aging, yet the shared biological mechanisms underlying this multimorbidity remain poorly defined. This study aimed to establish an integrative clinical-genetic framework to elucidate the common frailty factor, the 'F' factor, that captures the systemic vulnerabili...
Early identification of diabetes in older adults is essential for preventing complications, yet many high‑risk individuals remain undetected in community settings. Using recent cycles of the nationally representative Korea National Health and Nutrition Examination Survey (KNHANES 2020-2023), we developed and temporally validated an Extreme Gradient Boosting (XGBoost) model to rule-in diabetes amon...
BACKGROUND: Progression independent of relapse activity (PIRA) has been shown to account for a majority of the disability accumulation in relapsing-re...
Artificial intelligence (AI) is rapidly transforming the landscape of chronic medical conditions, such as cardio-kidney-metabolic (CKM) issues linked ...
RATIONALE: Ketogenic Diet Therapy (KDT) is an effective but complex treatment for paediatric drug-resistant epilepsy. Access to trained dietitians lim...
BACKGROUND: Sarcopenic obesity (SO) is closely associated with mild cognitive impairment (MCI). However, traditional body composition-based diagnostic...
In this issue, the following 4 articles are reviewed by Drs. Mark L. Moster and Deborah I. Friedman, most of which include authors who are members of ...
The liver's contribution to pulmonary arterial hypertension (PAH) pathogenesis remains unclear. We hypothesized that the liver promotes inflammatory i...
OBJECTIVE: Evidence on metformin's skeletal effects remains conflicting. We emulated a target trial to evaluate associations between metformin therapy...
Adverse birth outcomes such as low birth weight (LBW) increase the risk of metabolic disorders and hypertension later in life. Although previous studi...
Hypertensive intracerebral hemorrhage (ICH) is a devastating stroke subtype with high mortality and disability, yet reliable early risk biomarkers rem...
Diabetes mellitus (DM) is an escalating global public health concern, with a rapidly increasing burden in low- and middle-income countries, including ...
Although hypertriglyceridemia (HTG) is a significant contributor to lipid-associated pathologies such as atherosclerotic cardiovascular disease, its r...
Sepsis, as a severe complication of acute pancreatitis (AP), needs to be identified and treated as early as possible. The blood urea nitrogen-to-album...
Ageing heterogeneity hampers prevention and care. We used routine biochemical panels and unsupervised learning to identify latent phenotypes in commun...
Cyclosporine A (CsA) functions as a calcineurin inhibitor that perturbs T cell activation via calcineurin-nuclear factor of activated T cells (CaN-NFA...
BACKGROUND: Diseases exist on spectra of risk factors, cellular perturbations, organ dysfunction, and clinical manifestations. It is unknown whether t...
OBJECTIVES: The pathophysiology of idiopathic intracranial hypertension (IIH) is poorly understood and disease-specific biomarkers are lacking. We aim...
BACKGROUND: Lung adenocarcinoma (LUAD), the predominant histological subtype of non-small cell lung cancer, remains a leading cause of cancer-related ...
BACKGROUND AND AIMS: Steatotic liver disease (SLD) has emerged as an important risk factor for hepatocellular carcinoma (HCC), often in the absence of...